The Beneficial Impact of a Novel Pancreatic Polypeptide Analogue on Islet Cell Lineage
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094215 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Wuyun Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Centre, Schools of Biomedical Science and Pharmacy, Ulster University, Co. Londonderry, Coleraine BT52 1SA, UK. Hauptthemen laut MEDLINE: Pancreatic Polypeptide, Diabetes Mellitus, Experimental, Cell Lineage, Islets of Langerhans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes UK, Ulster University Research Funding.
Abstract (Originalsprache)
(Proline3)PP, or (P3)PP, is an enzymatically stable, neuropeptide Y4 receptor (NPY4R)-selective, pancreatic polypeptide (PP) analogue with established weight-lowering and pancreatic islet morphology benefits in obesity-diabetes. In the current study, we now investigate the impact of twice-daily (P3)PP administration (25 nmol/kg) for 11 days on islet cell lineage, using streptozotocin (STZ) diabetic Ins1Cre/+;Rosa26-eYFP and GluCreERT2;Rosa26-eYFP transgenic mice with enhanced yellow fluorescent protein (eYFP) labelling of beta-cell and alpha-cells, respectively. (P3)PP had no obvious impact on body weight or blood glucose levels in STZ-diabetic mice at the dose tested, but did return food intake towards control levels in Ins1Cre/+;Rosa26-eYFP mice. Notably, pancreatic insulin content was augmented by (P3)PP treatment in both Ins1Cre/+;Rosa26-eYFP and GluCreERT2;Rosa26-eYFP mice, alongside enhanced beta-cell area and reduced alpha-cell area. Beneficial (P3)PP-induced changes on islet morphology were consistently associated with decreased beta-cell apoptosis, while (P3)PP also augmented beta-cell proliferation in Ins1Cre/+;Rosa26-eYFP mice. Alpha-cell turnover rates were returned towards healthy control levels by (P3)PP intervention in both mouse models. In terms of islet cell lineage, increased transition of alpha- to beta-cells as well as decreased beta- to alpha-cell differentiation were shown to contribute towards the enhancement of beta-cell area in (P3)PP-treated mice. Together these data reveal, for the first time, sustained NPY4R activation positively modulates beta-cell turnover, as well as islet cell plasticity, to help preserve pancreatic islet architecture following STZ-induced metabolic stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes Research Centre, Schools of Biomedical Science and Pharmacy, Ulster University, Co. Londonderry, Coleraine BT52 1SA, UK.
ORCID-Profile: Nigel Irwin
Förderung
- Diabetes UK
- Ulster University Research Funding
Zitieren
APA
Zhu, W., Tanday, N., Flatt, P. R., & Irwin, N. (2025). The Beneficial Impact of a Novel Pancreatic Polypeptide Analogue on Islet Cell Lineage. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094215
Vancouver
Zhu W, Tanday N, Flatt PR, Irwin N. The Beneficial Impact of a Novel Pancreatic Polypeptide Analogue on Islet Cell Lineage. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094215
BibTeX
@article{Zhu2025,
author = {Zhu, Wuyun and Tanday, Neil and Flatt, Peter R and Irwin, Nigel},
title = {The Beneficial Impact of a Novel Pancreatic Polypeptide Analogue on Islet Cell Lineage},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094215}
}
EUVIMED